Medication info
Hudiang Duo Controlled Release Tablet 5/1000 mg (Empagliflozin, Metformin)

Hudiang Duo Controlled Release Tablet 5/1000 mg (Empagliflozin, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Huwons Co., Ltd.
Appearance
Gray, biconvex, oval-shaped controlled release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202501631 · Approved 2025.07.01 · Insurance code 670609580

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For antidiabetic therapy, determine the dose of this medicine based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily dose of each component: empagliflozin 25mg and metformin hydrochloride extended-release 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily in the evening with a meal. Increase the dose of metformin hydrochloride gradually to reduce gastrointestinal adverse reactions associated with metformin use. Take 1 tablet of this medicine 10/1000 mg extended-release tablet or 25/1000 mg extended-release tablet once daily. Patients taking this medicine 5/1000 mg extended-release tablet or 12.5/1000 mg extended-release tablet should take 2 tablets together once daily. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended initial total daily dose is empagliflozin 10 mg together with the patient's current dose of metformin. If empagliflozin 10 mg is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg. Patients switching from concomitant treatment with empagliflozin and metformin to this medicine should receive their previous doses of empagliflozin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. As dose adjustment according to renal function is necessary, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. No dose adjustment of this medicine is required in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60 mL/min/1.73m2], if the medicine is well tolerated and there are no other conditions that may increase the risk of lactic acidosis, it may be used with adjustment of the metformin hydrochloride dose as follows. - Since the starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. If creatinine clearance (CrCl) decreases to below 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to below 45 ml/min/1.73m2, this medicine must be discontinued immediately. Patients 75 years of age and older: Consider renal function and the risk of volume depletion.

Ingredients

Manufacturer
Huwons Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Poor blood sugar control
  • type 2 diabetes
  • cardiovascular disease
View approved original text

This medication contains both empagliflozin and metformin, and is used to assist in blood sugar control for adult patients with type 2 diabetes alongside dietary and exercise management. It is especially effective in patients whose blood sugar is not sufficiently controlled, and can also be used in patients with cardiovascular disease. However, information from professional clinical trials should be referred to regarding the cardiovascular event-related aspects. This medication helps improve blood sugar management and assists in diabetes treatment.

How to take

Adult dose

For antidiabetic therapy, determine the dose of this medicine based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily dose of each component: empagliflozin 25mg and metformin hydrochloride extended-release 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily in the evening with a meal. Increase the dose of metformin hydrochloride gradually to reduce gastrointestinal adverse reactions associated with metformin use. Take 1 tablet of this medicine 10/1000 mg extended-release tablet or 25/1000 mg extended-release tablet once daily. Patients taking this medicine 5/1000 mg extended-release tablet or 12.5/1000 mg extended-release tablet should take 2 tablets together once daily. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended initial total daily dose is empagliflozin 10 mg together with the patient's current dose of metformin. If empagliflozin 10 mg is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg. Patients switching from concomitant treatment with empagliflozin and metformin to this medicine should receive their previous doses of empagliflozin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. As dose adjustment according to renal function is necessary, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. No dose adjustment of this medicine is required in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60 mL/min/1.73m2], if the medicine is well tolerated and there are no other conditions that may increase the risk of lactic acidosis, it may be used with adjustment of the metformin hydrochloride dose as follows. - Since the starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. If creatinine clearance (CrCl) decreases to below 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to below 45 ml/min/1.73m2, this medicine must be discontinued immediately. Patients 75 years of age and older: Consider renal function and the risk of volume depletion.

Precautions

This medication is used to treat type 2 diabetes and helps lower blood sugar levels. While taking this medication, caution is required as a rare side effect, severe lactic acidosis, can occur. Lactic acidosis can lead to an excessive accumulation of lactate in the body, which can result in a dangerous condition and potentially lead to death. Additionally, taking this medication with other diabetes drugs may cause hypoglycemia, so careful monitoring of blood sugar levels is necessary. Patients with moderate to severe renal impairment, acute kidney issues, severe infection, or heart disease should not use this medication. Women who are pregnant or may become pregnant, patients with liver dysfunction, or patients in poor nutritional status should also avoid taking this medication. This medication contains lactose, so patients with lactose intolerance should refrain from taking it. During treatment, regular kidney function tests should be conducted, and especially elderly patients or those with slightly impaired kidney function should be tested more frequently. Patients at risk of reduced fluid volume, for instance, those with dehydration symptoms or severe vomiting or diarrhea, should take this medication with caution. This medication may increase the risk of genital infections and urinary tract infections; if such symptoms occur, medical professionals should be informed immediately. Vitamin B12 levels may decrease, so patients taking this medication long-term should have their vitamin B12 levels checked regularly. Alcohol consumption may increase the risk of side effects from this medication, so it is advisable to avoid excessive drinking while on this treatment. Patients scheduled for surgery must stop taking this medication at least 48 hours before surgery and should resume only after kidney function has returned to normal post-surgery. This medication should be swallowed whole without breaking, crushing, or chewing; the tablet coating may be excreted but this is normal. While taking this medication, if symptoms of hypoglycemia, lactic acidosis (such as fatigue, muscle pain, difficulty breathing, abdominal pain), or infection appear, consulting a doctor promptly is necessary. Elderly patients require particular attention, and it is customary not to administer the maximum dose. In cases of overdose, seek immediate medical attention and proper treatment, which may include blood dialysis.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • decreased and deficiency of vitamin B12
  • ketoacidosis
  • lactic acidosis
  • reduced fluid volume
Show 151 more
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • taste disorders
  • itching
  • rash
  • hives
  • erythema
  • angioedema
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • vomiting
  • nausea
  • gastric ulcer
  • colitis
  • ischemic colitis
  • colonic bleeding
  • chronic gastritis
  • constipation
  • gastritis
  • abdominal discomfort
  • anal incontinence
  • dry mouth
  • gastrointestinal disorders
  • gastroesophageal reflux disease
  • oral discomfort
  • salivary gland pain
  • headache
  • cerebral infarction
  • sensory loss
  • orthostatic dizziness
  • dizziness
  • drowsiness
  • facial paralysis
  • memory disorders
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • myasthenia
  • chest discomfort
  • chest pain
  • fever
  • chills
  • strange sensations
  • edema
  • pain
  • vascular stent stenosis
  • vascular stent thrombosis
  • weight loss
  • urinary stones
  • hematuria
  • overactive bladder
  • renal mass
  • urine retention
  • urinary pain
  • abnormal urination
  • vulvar pruritus
  • benign prostatic hyperplasia
  • cervical inflammation
  • hypercholesterolemia
  • dyslipidemia
  • hyperglycemia
  • hyponatremia
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosis
  • ocular discomfort
  • ocular congestion
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • traction retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • moist cough
  • allergic rhinitis
  • persistent phlegm
  • cough
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accidents
  • splenic injury
  • sternal fracture
  • angina
  • palpitations
  • Prinzmetal's angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • otalgia
  • orthostatic vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodules
  • anxiety

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way maintains the drug's effectiveness and prevents degradation.

Appearance and packaging

Appearance

Gray, biconvex, oval-shaped controlled release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.